• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾结石-尿酸盐作为一种尿激酶抑制剂。

Renal calculi-urate as a urokinase inhibitor.

作者信息

van Aswegen C H, Neitz A W, Becker P J, du Plessis D J

机构信息

Department of Urology, H.F. Verwoerd Hospital, University of Pretoria, Republic of South Africa.

出版信息

Urol Res. 1988;16(3):143-8. doi: 10.1007/BF00256008.

DOI:10.1007/BF00256008
PMID:2970708
Abstract

The formation of renal calculi is one of the most widely studied urinary ailments. Spectrophotometric analysis of urinary inhibition on the urokinase/plasmin system revealed a significant difference between subjects with and without renal calculi (P less than 0.001). The percentage urokinase/plasmin inhibition in the two groups was 77.1% for those with, and 47.1% for those without renal calculi. Because of the significant (P less than 0.015) positive correlation (r = 0.762) between the percentage inhibition of urokinase/plasmin and urinary urate concentration, the inhibition of urate on urokinase/plasmin and on plasmin and urokinase was investigated. The urokinase/plasmin system was inhibited up to 94.4% with 0.5 mM urate. Inhibition occurred with both low and high molecular weight urokinases. In order to determine which enzyme of the complex was inhibited, each was investigated independently and a 50% inhibition of urokinase activity was obtained with 4 mM urate. It was found that the urine of stone formers contained a higher concentration of urate than the urine of healthy subjects and that at the same time there was a decrease in urinary urokinase activity in these patients.

摘要

肾结石的形成是研究最为广泛的泌尿系统疾病之一。对尿液对尿激酶/纤溶酶系统的抑制作用进行分光光度分析发现,有肾结石和无肾结石的受试者之间存在显著差异(P小于0.001)。两组中尿激酶/纤溶酶的抑制百分比,有肾结石者为77.1%,无肾结石者为47.1%。由于尿激酶/纤溶酶抑制百分比与尿尿酸浓度之间存在显著的(P小于0.015)正相关(r = 0.762),因此研究了尿酸对尿激酶/纤溶酶以及纤溶酶和尿激酶的抑制作用。用0.5 mM尿酸可使尿激酶/纤溶酶系统的抑制率高达94.4%。低分子量和高分子量尿激酶均受到抑制。为了确定复合物中的哪种酶受到抑制,对每种酶进行了单独研究,用4 mM尿酸可使尿激酶活性受到50%的抑制。结果发现,结石形成者尿液中的尿酸浓度高于健康受试者的尿液,同时这些患者的尿激酶活性降低。

相似文献

1
Renal calculi-urate as a urokinase inhibitor.肾结石-尿酸盐作为一种尿激酶抑制剂。
Urol Res. 1988;16(3):143-8. doi: 10.1007/BF00256008.
2
Activation of pro-urokinase by plasmin: non-Michaelian kinetics indicates a mechanism of negative cooperativity.
Arch Biochem Biophys. 1989 Feb 1;268(2):438-46. doi: 10.1016/0003-9861(89)90311-1.
3
Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.健康印度人和肾结石患者血清及尿酸盐昼夜节律性的研究。
Prog Clin Biol Res. 1987;227B:305-13.
4
Laxative abuse as a cause for ammonium urate renal calculi.滥用泻药作为尿酸铵肾结石的一个病因。
J Urol. 1990 Feb;143(2):244-7. doi: 10.1016/s0022-5347(17)39923-8.
5
Evaluation of factors involved in calcium stone formation.钙结石形成相关因素的评估。
Miner Electrolyte Metab. 1987;13(3):201-8.
6
Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.酶原激活动力学。反式-4-(氨甲基)环己烷-1-羧酸和聚-D-赖氨酸对纤溶酶原激活的调节作用。
Biochem J. 1985 Jan 1;225(1):149-58. doi: 10.1042/bj2250149.
7
Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.人尿中一种新型尿激酶抑制剂的纯化与特性分析。血浆中的定量及初步特性分析。
J Biol Chem. 1986 Sep 25;261(27):12759-66.
8
Does urokinase play a role in renal stone formation?尿激酶在肾结石形成过程中起作用吗?
Med Hypotheses. 1997 Jul;49(1):57-9. doi: 10.1016/s0306-9877(97)90253-x.
9
Ammonium urate urinary stone: its surface structure and incidence in Japan.尿酸铵尿路结石:其表面结构及在日本的发病率
Int Urol Nephrol. 1989;21(3):275-9. doi: 10.1007/BF02559737.
10
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.人肉瘤细胞上尿激酶原和纤溶酶原的激活:一个具有表面结合反应物的蛋白水解系统。
J Cell Biol. 1989 May;108(5):1987-95. doi: 10.1083/jcb.108.5.1987.

引用本文的文献

1
Urinary plasmin inhibits TRPV5 in nephrotic-range proteinuria.尿纤溶酶抑制肾病范围蛋白尿中的 TRPV5。
J Am Soc Nephrol. 2012 Nov;23(11):1824-34. doi: 10.1681/ASN.2011111126. Epub 2012 Sep 27.
2
In vivo effects of urease-producing bacteria involved with the pathogenesis of infection-induced urolithiasis on renal urokinase and sialidase activity.产脲酶细菌在感染性尿路结石发病机制中与肾尿激酶和唾液酸酶活性相关的体内效应。
Urol Res. 1995;23(5):335-8. doi: 10.1007/BF00300023.
3
Pyelonephritis: renal urokinase and sialidase (neuraminidase) activity in rats fed a standard laboratory diet.

本文引用的文献

1
Urate does not influence the formation of calcium oxalate crystals in whole human urine at pH 5.3.
Clin Sci (Lond). 1982 Apr;62(4):421-5. doi: 10.1042/cs0620421.
2
Urinary trypsin inhibitor and urokinase activities in renal diseases.肾脏疾病中尿胰蛋白酶抑制剂和尿激酶的活性
Acta Haematol. 1982;67(2):109-13. doi: 10.1159/000207035.
3
Investigation of the substrate-binding site of human plasmin using tripeptidyl-p-nitroanilide substrates.
Thromb Res. 1980 Oct 15;20(2):199-206. doi: 10.1016/0049-3848(80)90385-0.
4
肾盂肾炎:喂食标准实验室饮食的大鼠的肾尿激酶和唾液酸酶(神经氨酸酶)活性
Urol Res. 1994;22(1):57-60. doi: 10.1007/BF00431551.
4
Pyelonephritis: renal urokinase activity in rats on essential fatty acid diets.肾盂肾炎:食用必需脂肪酸饮食的大鼠的肾脏尿激酶活性
Urol Res. 1994;22(3):127-30. doi: 10.1007/BF00571837.
5
The relationship between total urinary testosterone and renal calculi.
Urol Res. 1989;17(3):181-3. doi: 10.1007/BF00256248.
6
The effect of calcium and magnesium ions on urinary urokinase and sialidase activity.
Urol Res. 1992;20(1):41-4. doi: 10.1007/BF00294333.
7
Effects of bacteria involved with the pathogenesis of infection-induced urolithiasis on the urokinase and sialidase (neuraminidase) activity.与感染性尿路结石发病机制相关的细菌对尿激酶和唾液酸酶(神经氨酸酶)活性的影响。
Urol Res. 1992;20(6):393-7. doi: 10.1007/BF00294494.
Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.通过一种新的特异性检测方法测定静脉淤滞和运动过程中纤溶酶原激活物的释放情况。
Clin Chim Acta. 1983 Jan 24;127(2):279-88. doi: 10.1016/s0009-8981(83)80012-6.
5
Assay of urokinase activity in plasma with a chromogenic substrate.用显色底物测定血浆中尿激酶活性。
Thromb Res. 1981;22(5-6):573-8. doi: 10.1016/0049-3848(81)90056-6.
6
An aminopeptidase occurring in pig kidney. I. An improved method of preparation. Physical and enzymic properties.一种存在于猪肾中的氨肽酶。I. 一种改进的制备方法。物理性质和酶学性质。
Biochemistry. 1966 Jan;5(1):169-74. doi: 10.1021/bi00865a022.
7
The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.
J Biol Chem. 1986 Mar 15;261(8):3486-9.
8
Activation of plasminogen by pro-urokinase. I. Mechanism.尿激酶原对纤溶酶原的激活作用。I. 机制
J Biol Chem. 1986 Jan 25;261(3):1253-8.
9
Urinary and kidney cell plasminogen activator (urokinase).尿及肾细胞纤溶酶原激活物(尿激酶)。
Methods Enzymol. 1976;45:239-44. doi: 10.1016/s0076-6879(76)45023-1.
10
Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.正常细胞和恶性细胞的尿激酶及纤溶酶原激活剂的直接荧光测定:动力学和抑制剂谱
Proc Natl Acad Sci U S A. 1978 Feb;75(2):750-3. doi: 10.1073/pnas.75.2.750.